DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Karampeazis A, Voutsina A, Souglakos J et al.
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study.
Cancer 2013;
119: 2754-2764
We do not assume any responsibility for the contents of the web pages of other providers.